What systemic therapy would you recommend for axillary recurrence of triple negative secretory breast cancer previously treated with mastectomy alone?

The type of systemic chemotherapy for locoregional recurrence of triple negative breast cancer is not standardized. Based on the CALOR trial, the dealer's choice of systemic chemotherapy reduced the risk of breast cancer recurrence specifically in triple negative breast cancer. The patient has not r...